WuXi PharmaTech (Cayman) Inc. Research and Development Expense
WuXi PharmaTech (Cayman) Inc. reported Research and Development Expense of $21.21 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2015-04-15
| Period end | Research and Development Expense 12 month |
|---|---|
| 2014-12-31 | $21.21M 20-F · filed 2015-04-15 |
| 2013-12-31 | $10.95M 20-F · filed 2015-04-15 |
| 2012-12-31 | $8.14M 20-F · filed 2015-04-15 |
| 2011-12-31 | $5.41M 20-F · filed 2014-04-15 |
| 2010-12-31 | $368.00K 20-F · filed 2013-04-17 |